Pilot of a theoretically grounded psychologist-delivered intervention for fear of cancer recurrence (Conquer Fear)

Psycho-Oncology

Volumn 24, Issue 8, 2015, Pages 967-970

  Ben Smith, Allan ^a   Thewes, Belinda ^a   Turner, Jane ^b   Gilchrist, Jemma ^c   Fardell, Joanna ^a   Sharpe, Louise ^a   Bell, Melanie L ^a   Girgis, Afaf ^d   Grier, Maree ^e   Byrne, Donna ^f   Clutton, Samantha ^g   Butow, Phyllis ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f TOOWOOMBA HOSPITAL   (Australia)

^g CANCER COUNCIL QUEENSLAND   (Australia)

Author keywords

cancer; fear of cancer recurrence; metacognitive therapy: acceptance and commitment therapy; oncology; survivorship

Indexed keywords

ADULT; ASSESSMENT OF HUMANS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMMON SENSE MODEL; CONQUER FEAR; EFFECT SIZE; EMPLOYMENT STATUS; FACE VALIDITY; FEAR OF CANCER RECURRENCE; FEAR OF CANCER RECURRENCE INVENTORY; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL; HUMAN; IMPACT OF EVENTS SCALE; LETTER; MEDICAL HISTORY; NONBIOLOGICAL MODEL; PHOBIA; PILOT STUDY; PSYCHOTHERAPY; QUALITY OF LIFE; RELATIONAL FRAME THEORY; RELIABILITY; SELF REGULATORY EXECTIVE FUNCTION MODEL; THEORY; ADOLESCENT; AGED; FEAR; PSYCHOLOGY; SURVIVOR; TUMOR RECURRENCE;

ADOLESCENT; AGED; FEAR; HUMANS; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; SURVIVORS;

EID: 84937786312     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3775     Document Type: Letter

References (18)

1. Vickberg SMJ,. The concerns about recurrence scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 2003; 25: 16-24.
2. Simard S, Thewes B, Humphris G, et al., Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 2013; 7: 300-322.
3. Thewes B, Brebach R, Dzidowska M, et al., Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psycho-Oncology 2014; 23: 390-396. DOI: 10.1002/pon.3423.
4. Herschbach P, Book K, Dinkel A, et al., Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer 2010; 18: 471-479. DOI: 10.1007/s00520-009-0696-1.
5. Humphris GM, Ozackinci G,. The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Brit J Health Psych 2008; 13: 223-230.
6. Lebel S, Maheu C, Lefebvre M, et al., Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 2014; 8: 485-496.
7. Leventhal H, Diefenbach M, Leventhal EA,. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognitive Ther Res 1992; 16: 143-163.
8. Wells A, Matthews G,. Modelling cognition in emotional disorder: the S-REF model. Behav Res Ther 1996; 34: 881-888.
9. Hayes SC, Luoma JB, Bond FW, et al., Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 2006; 44: 1-25. 10.1016/j.brat.2005.06.006.
10. Butow P, Bell M, Smith A, et al., Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer 2013; 13: 201. DOI: 10.1186/1471-2407-13-201.
11. Simard S, Savard J,. Screening and Psychiatric Comorbidity of Clinical Fear of Cancer Recurrence. (4th edn), Canadian Breast Cancer Research Alliance Reasons for Hope Scientific Conference. Vancouver: Canada, 2008.
12. Simard S, Savard J,. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2009; 17: 241-251.
13. Horowitz MJ, Wilner N, Alvarez W,. Impact of event scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-218.
14. Webster K, Cella D, Yost K,. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003; 1: 79. DOI: 10.1186/1477-7525-1-79.
15. Kenward MG, Roger JH,. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997; 53: 983-997.
16. Jacobson NS, Truax P,. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psych 1991; 59: 12-19.
17. Norman G, Sloan J, Wyrwich K,. The truly remarkable universality of half a standard deviation: confirmation through another look. Expert Rev Pharmacoecon Outcomes Res 2004; 4: 581-585.
18. King MT, Stockler MR, Cella DF, et al., Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G. J Clin Epidemiol 2010; 63: 270-281. DOI: 10.1016/j.jclinepi.2009.05.001.